According to many important studies, HER2-positive disease, the existence of more than two metastatic sites at BC diagnosis, HR negative, and a more advanced stage of the original tumor were all linked to a greater risk of breast cancer BMs (4, 8, 9). This evidence concerns the gene ERBB2 and breast carcinoma.